Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Gut hormone

Peptide YY

Peptide YY (PYY) is a 36-amino-acid gut hormone released from intestinal L-cells after eating, where it contributes to satiety and slows gastric emptying.

By The Peptides Codex Editorial TeamIndividual review date not recorded

Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.

Length
36 aa
Class
Gut hormone
Function
Post-meal satiety signaling; slows gastric emptying
Context
Endogenous hormone widely studied in appetite and energy-balance research

A satiety hormone from the same L-cells that make GLP-1.

Also known as: PYY · peptide tyrosine tyrosine

Part of the Metabolic & GLP-1 peptides cluster

Overview

Peptide YY (PYY) is a 36-amino-acid gut hormone released from intestinal L-cells after eating, where it contributes to satiety and slows gastric emptying. Named for its tyrosine residues at each end, it is a heavily studied signal in appetite and energy-balance research.

Source & context

Biological / chemical source: Intestinal L-cells (ileum and colon)

Primary research or clinical context: Endogenous hormone widely studied in appetite and energy-balance research

PYY(3-36) and the receptor family

The enzyme DPP-4 trims full-length PYY(1-36) into PYY(3-36), shifting its preference among neuropeptide-Y (NPY) family receptors. This active fragment is the form most associated with appetite research — a clear example of how proteolytic processing changes a peptide's receptor selectivity and biology.

Co-secretion with GLP-1

PYY is released from the same L-cells that secrete GLP-1, so the two hormones rise together after meals and are often studied side by side. This page describes that physiology for educational purposes and makes no claims about weight-management outcomes or products.

Sequence

One-letter sequence commonly cited for Peptide YY (educational; isoforms and modifications may differ):

YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY

YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY

Peptide YY36 aa · C194H294N54O58 · ≈ 4,311 DaPEPTIDESCODEX.COMN-terminus →→ C-terminusY1P2I3K+4P5E−6A7P8G9E−10D−11A12S13P14E−15E−16L17N18R+19Y20Y21A22S23L24R+25H26Y27L28N29L30V31T32R+33Q34R+35Y36nonpolarpolaracidicbasicGly / Pronon-canonical (X)Hydropathy (Kyte–Doolittle): ▮ hydrophobic (cyan) / ▮ hydrophilic (rose) · Side-chain charge at pH 7: + / −
Peptide YY — Structure cardDownload SVG
Y1P2I3K4P5E6A7P8G9E10D11A12S13P14E15E16L17N18R19Y20Y21A22S23L24R25H26Y27L28N29L30V31T32R33Q34R35Y36
Helical wheel projection

Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.

Analyze sequences in the playground →

Structure & chemistry

Molecular identity & reference confidence

Source-supported reference

Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.

Molecular form
Peptide YY (source record; form not independently established)
Species
Not established by this molecular identity audit
Termini (N / C)
Not specified / Not specified

Average reference mass

Reference policy updated: 2026-10-05

Molecular formula
C194H294N54O58
Average reference mass
≈ 4,311
Identifiers

Chemistry values: PubChem, IUPHAR/BPS Guide to Pharmacology · fetched 2026-10-01.

Clinical development snapshot

ClinicalTrials.gov lists 41 registered studies with “Peptide YY” as an intervention (snapshot 2026-10-01). A registry footprint is not evidence of efficacy or approval.

Registered studies
41
Highest phase reached
Phase 4
Active in latest 100
2
Most recent update
2026-07-22
Most recently updated studies
NCTTitlePhaseStatusUpdated
NCT06818032Avocado and Postprandial ResponsesNot applicablecompleted2026-07-22
NCT07540949Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With ObesityNot applicablerecruiting2026-04-21
NCT05725681Satiety of High-Protein Ramen NoodlesNot applicablecompleted2025-04-23
NCT03338387Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in BulimiaPhase 2enrolling by invitation2025-02-19
NCT05822167Effect of Food Temperature and Diet Composition on Satiety, Satiety Hormones, Chewing Time and Neuronal ActiviNot applicablecompleted2024-07-24
NCT02381249The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal SurgeryNot applicablecompleted2023-11-27
See all on ClinicalTrials.gov →
Concentration math

Peptide YY — reconstitution calculator

Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.

Reference form: Peptide YY (source record; form not independently established)Average reference mass: 4,311 Da

Syringe graduation
Solution concentration
5 mg/mL5,000 mcg/mL
mcg

Enter an amount to see the volume it corresponds to.

Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.

Open the Peptide YY calculator on its own page →

FAQ about Peptide YY

What is Peptide YY?+

Peptide YY (PYY) is a 36-amino-acid gut hormone released from intestinal L-cells after eating, where it contributes to satiety and slows gastric emptying. Named for its tyrosine residues at each end, it is a heavily studied signal in appetite and energy-balance research.

What Canadian product status is recorded for Peptide YY?+

Canadian product status for Peptide YY has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.

What is the typical length of Peptide YY?+

Peptide YY is commonly described as approximately 36 amino acids (Gut hormone).

Related peptides

Dihexa
Angiotensin IV-derived peptidomimetic (research compound)
Dihexa (PNB-0408; C27H44N4O5, ≈505 Da) is a small, orally available, blood-brain-barrier-permeable peptidomimetic derived from angiotensin IV: N-hexanoyl-tyrosyl-isoleucyl-6-aminohexanamide. It was designed as a metabolically stabilised procognitive agent and is proposed to act by potentiating hepatocyte growth factor signalling at the c-Met receptor. Its evidence is entirely preclinical — rodent memory models and cell work — with no registered human trial and no approval; a central 2014 mechanism paper has been retracted.
Thymosin beta-4
Actin-sequestering peptide
Thymosin beta-4 is a naturally occurring 43-amino-acid peptide and the principal actin-sequestering molecule in many cell types. The research compound TB-500 is derived from an active region of this larger peptide. Thymosin beta-4 is investigational and not authorized by Health Canada; this page is educational only.
Pramlintide
Amylin analog
Pramlintide is a synthetic analog of the pancreatic hormone amylin, designed with proline substitutions so it stays soluble rather than aggregating. It is an approved prescription medicine in the United States used alongside insulin, and is a common case study in peptide formulation and analog design.
Oxyntomodulin
Gut hormone
Oxyntomodulin is a 37-amino-acid gut hormone released from intestinal L-cells after eating. Because it activates both the GLP-1 and glucagon receptors on its own, it is frequently cited as the natural inspiration for engineered dual-agonist metabolic peptides.

References & further reading

  1. 1.Chandarana et al. (2008). Peptide YY. Curr Opin Endocrinol Diabetes Obes
  2. 2.Pierre et al. (2023). Peptide YY: A Paneth cell antimicrobial peptide that maintains Candida gut commensalism. Science
  3. 3.Stanley et al. (2004). Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am J Physiol Gastrointest Liver Physiol
  4. 4.Tough et al. (2024). Enteroendocrine cell-derived peptide YY signalling is stimulated by pinolenic acid or Intralipid and involves coactivation of fatty acid receptors FFA1, FFA4 and GPR119. Neuropeptides
  5. 5.Reddy et al. (2024). Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction. Eur Heart J
  6. 6.Lafferty et al. (2018). Emerging therapeutic potential for peptide YY for obesity-diabetes. Peptides
  7. 7.Persaud et al. (2014). Peptide YY: more than just an appetite regulator. Diabetologia
  8. 8.Tschöp et al. (2007). Peptide YY: obesity's cause and cure?. Am J Physiol Endocrinol Metab
  9. 9.PubChem — compound summary for Peptide YY (CID 56841989)
  10. 10.Wikipedia — Peptide YY
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Peptide YY educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.